vs

Side-by-side financial comparison of Ellington Financial Inc. (EFC) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Ellington Financial Inc. is the larger business by last-quarter revenue ($78.2M vs $76.4M, roughly 1.0× PROCEPT BioRobotics Corp). Ellington Financial Inc. runs the higher net margin — 28.9% vs -39.1%, a 68.0% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (11.9% vs 8.7%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (31.0% CAGR vs 1.8%).

Ellington Management Group is an American hedge fund firm. As of June 2019, the firm was reportedly managing $8.5 billion in structured products and other credit instruments.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

EFC vs PRCT — Head-to-Head

Bigger by revenue
EFC
EFC
1.0× larger
EFC
$78.2M
$76.4M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+3.2% gap
PRCT
11.9%
8.7%
EFC
Higher net margin
EFC
EFC
68.0% more per $
EFC
28.9%
-39.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
31.0%
1.8%
EFC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EFC
EFC
PRCT
PRCT
Revenue
$78.2M
$76.4M
Net Profit
$22.6M
$-29.8M
Gross Margin
60.6%
Operating Margin
7.4%
-40.6%
Net Margin
28.9%
-39.1%
Revenue YoY
8.7%
11.9%
Net Profit YoY
-26.2%
-58.3%
EPS (diluted)
$0.10
$-0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EFC
EFC
PRCT
PRCT
Q4 25
$78.2M
$76.4M
Q3 25
$82.8M
$83.3M
Q2 25
$92.5M
$79.2M
Q1 25
$82.9M
$69.2M
Q4 24
$72.0M
$68.2M
Q3 24
$67.0M
$58.4M
Q2 24
$91.2M
$53.4M
Q1 24
$75.5M
$44.5M
Net Profit
EFC
EFC
PRCT
PRCT
Q4 25
$22.6M
$-29.8M
Q3 25
$29.5M
$-21.4M
Q2 25
$42.9M
$-19.6M
Q1 25
$31.6M
$-24.7M
Q4 24
$30.7M
$-18.9M
Q3 24
$16.2M
$-21.0M
Q2 24
$52.3M
$-25.6M
Q1 24
$26.9M
$-26.0M
Gross Margin
EFC
EFC
PRCT
PRCT
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Q1 24
56.2%
Operating Margin
EFC
EFC
PRCT
PRCT
Q4 25
7.4%
-40.6%
Q3 25
31.1%
-27.8%
Q2 25
38.3%
-28.0%
Q1 25
37.3%
-39.7%
Q4 24
28.0%
-28.9%
Q3 24
24.0%
-38.4%
Q2 24
52.8%
-50.3%
Q1 24
42.2%
-62.1%
Net Margin
EFC
EFC
PRCT
PRCT
Q4 25
28.9%
-39.1%
Q3 25
35.7%
-25.7%
Q2 25
46.4%
-24.7%
Q1 25
38.2%
-35.8%
Q4 24
42.6%
-27.6%
Q3 24
24.1%
-35.9%
Q2 24
57.4%
-48.0%
Q1 24
35.6%
-58.3%
EPS (diluted)
EFC
EFC
PRCT
PRCT
Q4 25
$0.10
$-0.54
Q3 25
$0.29
$-0.38
Q2 25
$0.45
$-0.35
Q1 25
$0.35
$-0.45
Q4 24
$0.23
$-0.34
Q3 24
$0.19
$-0.40
Q2 24
$0.62
$-0.50
Q1 24
$0.32
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EFC
EFC
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$201.9M
$286.5M
Total DebtLower is stronger
$51.6M
Stockholders' EquityBook value
$1.8B
$365.9M
Total Assets
$19.4B
$508.1M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EFC
EFC
PRCT
PRCT
Q4 25
$201.9M
$286.5M
Q3 25
$184.8M
$294.3M
Q2 25
$211.0M
$302.7M
Q1 25
$203.3M
$316.2M
Q4 24
$192.4M
$333.7M
Q3 24
$217.7M
$196.8M
Q2 24
$198.5M
$214.1M
Q1 24
$187.5M
$225.6M
Total Debt
EFC
EFC
PRCT
PRCT
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Q1 24
$51.4M
Stockholders' Equity
EFC
EFC
PRCT
PRCT
Q4 25
$1.8B
$365.9M
Q3 25
$1.8B
$380.3M
Q2 25
$1.7B
$385.8M
Q1 25
$1.6B
$389.2M
Q4 24
$1.6B
$402.2M
Q3 24
$1.6B
$241.2M
Q2 24
$1.6B
$251.8M
Q1 24
$1.5B
$264.0M
Total Assets
EFC
EFC
PRCT
PRCT
Q4 25
$19.4B
$508.1M
Q3 25
$17.8B
$511.5M
Q2 25
$17.1B
$513.1M
Q1 25
$16.6B
$519.4M
Q4 24
$16.3B
$534.0M
Q3 24
$16.0B
$374.1M
Q2 24
$15.1B
$374.4M
Q1 24
$15.1B
$382.9M
Debt / Equity
EFC
EFC
PRCT
PRCT
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EFC
EFC
PRCT
PRCT
Operating Cash FlowLast quarter
$-925.5M
$-10.3M
Free Cash FlowOCF − Capex
$-12.2M
FCF MarginFCF / Revenue
-15.9%
Capex IntensityCapex / Revenue
0.0%
2.4%
Cash ConversionOCF / Net Profit
-40.92×
TTM Free Cash FlowTrailing 4 quarters
$-58.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EFC
EFC
PRCT
PRCT
Q4 25
$-925.5M
$-10.3M
Q3 25
$-290.4M
$-6.6M
Q2 25
$-210.5M
$-15.0M
Q1 25
$-126.4M
$-17.0M
Q4 24
$-430.5M
$-32.4M
Q3 24
$-141.7M
$-18.8M
Q2 24
$-88.6M
$-15.7M
Q1 24
$-59.5M
$-32.3M
Free Cash Flow
EFC
EFC
PRCT
PRCT
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
Q1 24
$-34.2M
FCF Margin
EFC
EFC
PRCT
PRCT
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Q1 24
-76.9%
Capex Intensity
EFC
EFC
PRCT
PRCT
Q4 25
0.0%
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
0.0%
1.7%
Q3 24
0.0%
0.4%
Q2 24
0.0%
2.0%
Q1 24
0.0%
4.4%
Cash Conversion
EFC
EFC
PRCT
PRCT
Q4 25
-40.92×
Q3 25
-9.84×
Q2 25
-4.90×
Q1 25
-3.99×
Q4 24
-14.04×
Q3 24
-8.76×
Q2 24
-1.69×
Q1 24
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EFC
EFC

Segment breakdown not available.

PRCT
PRCT

Hand Pieces And Other Consumables$34.1M45%
System Sales And Rentals$27.5M36%
Other$9.8M13%
Service Revenue$5.0M7%

Related Comparisons